ATLANTISCAN
Active Ingredient: FLUDEOXYGLUCOSE 18F
Product Overview
About ATLANTISCAN
ATLANTISCAN is a diagnostic imaging agent used in positron emission tomography (PET) scans to visualize glucose metabolism in the body. It contains the active ingredient Fludeoxyglucose 18F, a radioactive tracer that accumulates in areas with high glucose uptake.
Key Benefits & Uses
- Visualizing glucose metabolism in the body, particularly in cancer cells, brain, and other tissues.
- Assisting in the diagnosis and staging of various cancers, including breast, lung, colon, and lymphoma.
- Helping to identify areas of inflammation and infection in the body.
Active Ingredient & Action
Fludeoxyglucose 18F is a glucose analogue that is taken up by cells through the same transport mechanisms as glucose. In areas with high glucose metabolism, such as cancer cells, ATLANTISCAN accumulates and is visualized by PET scans, allowing for the detection and monitoring of these cells.
Important Notes
ATLANTISCAN is a prescription medication that should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosing and administration instructions to ensure safe and effective use. Patients should also be aware of the potential risks associated with radiation exposure and the importance of proper disposal of radioactive waste.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
